May 24, 2023 08:30AM
Apr 5, 2023 08:30AM
Apr 3, 2023 08:30AM
Mar 28, 2023 08:32AM
Mar 28, 2023 08:30AM
Mar 1, 2023 08:30AM
Feb 1, 2023 08:30AM ResolutionRx Ltd, a wholly owned subsidiary of RespireRx Pharmaceuticals Inc. Enters into LOI and Term Sheet with Radium Capital for the financing of anticipated Research and Development Credits
Jan 23, 2023 08:30AM
Jan 12, 2023 08:30AM
Dec 5, 2022 08:30AM
Nov 17, 2022 08:45AM
Nov 10, 2022 08:45AM
Nov 7, 2022 08:45AM
Aug 8, 2022 08:00AM RespireRx Pharmaceuticals Inc. Announces that Sleep Review has discussed the RespireRx Dronabinol Obstructive Sleep Apnea (OSA) Program in its June 13, 2022 Edition
May 24, 2022 08:00AM
May 17, 2022 08:00AM
May 16, 2022 08:00AM
Mar 23, 2022 08:00AM
Mar 16, 2022 08:00AM
Mar 7, 2022 08:00AM
Jan 24, 2022 07:00AM RespireRx Pharmaceuticals Inc. Announces Publication of a Manuscript Describing Its Newest Neuromodulator for Pharmacoresistant Epilepsy and Chronic Pain
Dec 14, 2021 08:18AM
Dec 6, 2021 08:45AM
Nov 30, 2021 08:45AM
Nov 29, 2021 08:45AM
Nov 22, 2021 08:45AM
Nov 4, 2021 08:45AM
Jun 8, 2021 06:20PM RespireRx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference
May 12, 2021 09:15AM
Apr 22, 2021 08:45AM
Feb 8, 2021 09:30PM
Feb 8, 2021 08:30AM
Jan 8, 2021 08:00AM
Jan 5, 2021 04:05PM

1,203,420 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All